GILD vs RPD · P/E 18, rev $7.80B vs P/E 59, rev $420.6M
Gilead Sciences Inc (GILD) versus Rapid7 Inc (RPD) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Rapid7 Inc (RPD) is a software - infrastructure company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported RPD revenue for 2026-06-30 was $420.6M. Net income was $7.2M. RPD currently screens at market cap $1.57B and trailing P/E 59.4.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. RPD currently screens at market cap $1.57B and trailing P/E 59.4.
Not investment advice. Open the GILD and RPD stock pages for the full models.
Not investment advice.